Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr Koren Ariel, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT00971984
First received: September 3, 2009
Last updated: August 30, 2015
Last verified: August 2015
  Purpose
The study intends to summarize the clinical and laboratory characteristics of children with hemolytic anemia diagnosed as having alpha thalassemia mutations.

Condition Intervention
Thalassemia Alpha
Hemolytic Anemia
Other: Medical records summary

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel

Resource links provided by NLM:


Further study details as provided by HaEmek Medical Center, Israel:

Primary Outcome Measures:
  • Analysis of the Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia [ Time Frame: One year ] [ Designated as safety issue: No ]
    Analysis of the Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia


Enrollment: 50
Study Start Date: October 2009
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Alpha thalassemia patients
Patients diagnosed with alpha thalassemia mutations and anemia
Other: Medical records summary
Summary of Medical files and laboratory results.

Detailed Description:
Fifty children and adolescents diagnosed as having alpha thalassemia will be studied, the clinical characteristics and hematology analysis will be summarized.
  Eligibility

Ages Eligible for Study:   up to 20 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
A group of 50 children that underwent workup due to hemolytic anemia and were further diagnosis as suffering from clinical alpha thalassemia.
Criteria

Inclusion Criteria:

  • All the patients that were studied at the pediatric hematology unit ant the Ha'Emek Medical Center

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00971984

Locations
Israel
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, Israel, 18101
Sponsors and Collaborators
HaEmek Medical Center, Israel
  More Information

Responsible Party: Dr Koren Ariel, Head of Pediatric Hematology Unit and Pediatric Dpt B, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier: NCT00971984     History of Changes
Other Study ID Numbers: 0074-09-EMC 
Study First Received: September 3, 2009
Last Updated: August 30, 2015
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Thalassemia
Anemia, Hemolytic
Alpha-Thalassemia
Anemia, Hemolytic, Congenital
Anemia
Hematologic Diseases
Hemoglobinopathies
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on August 22, 2016